非酒精性脂肪性肝病(NAFLD)也是我国越来越重要的慢性肝病问题[1]。我科自2012年3月至2012年9月间使用水飞蓟宾胶囊治疗56例糖尿病并非酒精性脂肪肝患者取得了满意疗效,现报道如下:1资料与方法全部病例资料均为2012年3月至2012年9月在我科住院治疗患者,总病例数112人;男性78例,女性34例;年龄35~68岁;少数名族72例,汉族40例。入选患者符合《非酒精性脂肪肝病诊疗指南》中的诊断标准[2]。同时上述患者符合WHO1999年糖尿病诊断和分型 Non-alcoholic fatty liver disease (NAFLD) is also an increasingly important chronic liver disease in China [1]. Our department from March 2012 to September 2012 use of silybin capsules in 56 patients with non-alcoholic fatty liver disease and diabetes have achieved satisfactory results are reported below: 1 Materials and Methods All cases are 2012 3 From January to September 2012, there were 112 hospitalized patients in our department. There were 78 males and 34 females, aged 35-68 years old. There were 72 ethnic minorities and 40 Han nationality patients. The selected patients met the diagnostic criteria in the Guide to Diagnosis and Treatment of Non-alcoholic Fatty Liver Disease [2]. At the same time, the above patients meet WHO1999 diabetes diagnosis and classification